tiprankstipranks
Trending News
More News >
Sinco Pharmaceuticals Holdings Ltd. (HK:6833)
:6833
Hong Kong Market

Sinco Pharmaceuticals Holdings Ltd. (6833) Financial Statements

Compare
0 Followers

Sinco Pharmaceuticals Holdings Ltd. Financial Overview

Sinco Pharmaceuticals Holdings Ltd.'s market cap is currently HK$386.25M. The company's EPS TTM is HK$0.022; its P/E ratio is 8.48; and it has a dividend yield of 1.05%. Sinco Pharmaceuticals Holdings Ltd. is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 2.82B¥ 2.54B¥ 2.27B¥ 2.02B¥ 2.05B
Gross Profit¥ 299.94M¥ 323.28M¥ 305.87M¥ 364.95M¥ 273.83M
Operating Income¥ 94.94M¥ 108.17M¥ 101.22M¥ 192.55M¥ 143.79M
EBITDA¥ 132.60M¥ 126.01M¥ 109.01M¥ 197.69M¥ 152.05M
Net Income¥ 42.05M¥ 42.35M¥ 69.46M¥ 135.08M¥ 118.14M
Balance Sheet
Cash & Short-Term Investments¥ 308.32M¥ 437.92M¥ 329.14M¥ 326.05M¥ 143.76M
Total Assets¥ 2.00B¥ 1.89B¥ 1.42B¥ 1.23B¥ 1.25B
Total Debt¥ 350.54M¥ 251.40M¥ 192.41M¥ 340.95M¥ 82.13M
Net Debt¥ 42.22M¥ -186.52M¥ -136.73M¥ 14.90M¥ -61.63M
Total Liabilities¥ 1.34B¥ 1.26B¥ 820.52M¥ 857.88M¥ 1.09B
Stockholders' Equity¥ 662.88M¥ 628.05M¥ 603.81M¥ 374.89M¥ 165.34M
Cash Flow
Free Cash Flow¥ -268.05M¥ 289.16M¥ 22.39M¥ 282.19M¥ 136.93M
Operating Cash Flow¥ -232.88M¥ 353.70M¥ 75.08M¥ 305.71M¥ 137.30M
Investing Cash Flow¥ -52.87M¥ -63.63M¥ -119.27M¥ -22.73M¥ -46.84M
Financing Cash Flow¥ 154.59M¥ -189.73M¥ 35.04M¥ -97.11M¥ -169.88M
Currency in CNY

Sinco Pharmaceuticals Holdings Ltd. Earnings and Revenue History

Sinco Pharmaceuticals Holdings Ltd. Debt to Assets

Sinco Pharmaceuticals Holdings Ltd. Cash Flow

Sinco Pharmaceuticals Holdings Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis